Location History:
- Ascot Vale, AU (1999 - 2003)
- Parkville, AU (2001 - 2003)
- Melbourne, AU (2008)
Company Filing History:
Years Active: 1999-2008
Title: Brendan Scott Crabb: Innovator in Veterinary Vaccines
Introduction
Brendan Scott Crabb is a notable inventor based in Melbourne, Australia. He has made significant contributions to the field of veterinary medicine, particularly in the development of vaccines for animals. With a total of 6 patents to his name, Crabb's work focuses on enhancing animal health and immunity.
Latest Patents
One of Crabb's latest patents is for an attenuated circovirus. This isolated attenuated circovirus features a mutation in the viral nucleic acid encoding viral protein 2 (VP2). It is particularly suitable for use in conferring immunity in animals, especially birds. Another significant patent involves equine herpesvirus glycoproteins. This vaccine is designed for the selective immunization of horses against EHV4 and/or EHV1. It comprises at least one of the EHV4 virus or EHV1 virus, wherein a portion of the gG gene that elicits a type-specific response has been deleted. Additionally, antibodies that specifically bind to epitopes of EHV4 gG or EHV1 are also provided.
Career Highlights
Brendan Scott Crabb is affiliated with The University of Melbourne, where he continues to advance his research and innovations in veterinary vaccines. His work has garnered attention for its potential impact on animal health and disease prevention.
Collaborations
Crabb has collaborated with notable colleagues, including Michael Justin Studdert and Li Feng. These partnerships have contributed to the development of his innovative patents and research initiatives.
Conclusion
Brendan Scott Crabb is a prominent figure in the field of veterinary medicine, with a focus on developing vaccines that enhance animal immunity. His contributions through his patents reflect his commitment to improving animal health and welfare.